Company Information
CIN
Status
Date of Incorporation
26 April 1947
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 June 2023
Paid Up Capital
449,327,400
Authorised Capital
6,550,000,000
Directors
Anita Marangoly George
Director/Designated Partner
about 2 years ago
about 2 years ago
Puneet Yadu Dalmia
Director/Designated Partner
about 2 years ago
about 2 years ago
Shikha Sanjaya Sharma
Director/Designated Partner
over 2 years ago
over 2 years ago
Anand Ajay Piramal
Director/Designated Partner
over 2 years ago
over 2 years ago
Nandini Ajay Piramal
Director/Designated Partner
over 2 years ago
over 2 years ago
Rajesh Ratanlal Laddha
Director/Designated Partner
over 2 years ago
over 2 years ago
Gautam Bhailal Doshi
Director/Designated Partner
over 2 years ago
over 2 years ago
Vijay Kantilal Shah
Director/Designated Partner
over 2 years ago
over 2 years ago
Ajay Gopikisan Piramal
Director/Designated Partner
over 2 years ago
over 2 years ago
Ramadorai Subramanian
Director/Designated Partner
over 2 years ago
over 2 years ago
Anjali Bansal
Director/Designated Partner
over 2 years ago
over 2 years ago
Rajiv Mehrishi
Director/Designated Partner
almost 3 years ago
almost 3 years ago
Upma Goel
Director/Designated Partner
almost 3 years ago
almost 3 years ago
Bipin Singh
Director/Designated Partner
almost 3 years ago
almost 3 years ago
Kunal Bahl
Director/Designated Partner
over 4 years ago
over 4 years ago
Suhail Amin Nathani
Director/Designated Partner
over 4 years ago
over 4 years ago
Khushru Burjor Jijina
Director/Designated Partner
over 4 years ago
over 4 years ago
Arundhati Bhattacharya
Director
over 6 years ago
over 6 years ago
Raghunath Anant Mashelkar
Director
over 12 years ago
over 12 years ago
Swati Ajay Piramal
Director/Designated Partner
about 13 years ago
about 13 years ago
Rajesh Khanna
Nominee Director
over 23 years ago
over 23 years ago
Narayanan Vaghul
Director/Designated Partner
over 28 years ago
over 28 years ago
Past Directors
Vivek Valsaraj
Cfo(kmp)
about 8 years ago
about 8 years ago
Siddharth Nanalal Mehta
Director
over 12 years ago
over 12 years ago
Gautam Banerjee
Director
over 12 years ago
over 12 years ago
Goverdhan Mehta
Director
over 12 years ago
over 12 years ago
Amit Ranbir Chandra
Additional Director
over 14 years ago
over 14 years ago
Santhanam Narayanaswamy
Additional Director
about 18 years ago
about 18 years ago
Michael Jude Fernandes
Whole Time Director
almost 20 years ago
almost 20 years ago
Keki Bomi Dadiseth
Director
about 20 years ago
about 20 years ago
Leonard Joseph Peter Dsouza
Company Secretary
about 25 years ago
about 25 years ago
Yezdi Hirji Malegam
Director
over 28 years ago
over 28 years ago
Rajendra Ambalal Shah
Director
over 47 years ago
over 47 years ago
Patents
The present invention relates to a pharmaceutical composition comprising clobazam or its pharmaceutically acceptable salt(s) or solvate(s) thereof of defined particle size and one or more pharmaceutically acceptable excipients.
The present invention provides an improved process for preparation of the substantially pure
trazodone and its hydrochloride salt. The process comprises reaction of the compound-II (as
described) with the compound-Ill (as described) optionally in the presence of an inorganic
base, and a catalyst; wherein in the s...
The present invention provides an improved process for preparation of the substantially pure (3aR,7aR)-4,-(benzo[d]isothiazol-3-yl)octahydrospiro[isoindole-2,r-piperazin]-r-ium methanesulfonate (referred to as compound-II), which is useful as a key intermediate for the synthesis of lurasidone ((3aR,4S,7R,7aS)-2-{(lR...
Abstract
The present invention provides an improved process for preparation of 3-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-l-yJ)ethyl)-2-rnethyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[l,2-a]pyrimidin-9-yl palmitate (paliperidone palmitate) containing dimer compound (referred to as 'PP-Dime...
The present invention relates to the pyrrolidine substituted with flavone derivatives represented by the compounds of Formula (I) or a pharmaceutically acceptable salt a solvate a stereoisomer or a diastereoisomer thereof for use in the treatment of cancers associated with human papillomavirus. The present invention...
The present invention relates to an improved process for the preparation of l,3,5-triazine-2,4,6(lH,3H,5H)-trione ("Triglycidylisocyanurate (TGIC) or the compound of formula I") comprising reacting cyanuric acid (the compound of formula III) with 3 to 7 molar equivalents of epichlorohydrin in an autoclave at a tempe...
The present invention relates to a pharmaceutical combination for use in the treatment of squamous cell carcinoma comprising a CDK inhibitor selected from the compounds of formula (I); or a pharmaceutically acceptable salt thereof and one or more antineoplastic agents selected from sorafenib lapatinib erlotinib cisp...
The present invention relates to fused heterocyclic compound of Formula (I) a stereoisomer a tautomer a pharmaceutically acceptable salt a pharmaceutically acceptable solvate a prodrug a polymorph N oxide S oxide or a carboxylic acid isostere thereof; processes for their preparation; pharmaceutical compositions comp...
The present invention relates to an improved process for the preparation of the dihydrochloride monohydrate salt of (S)-2-amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole (the compound of formula I) comprising reacting the compound of formula II with n-propanal and sodium borohydride using a mixture of methanol...
The present invention provides a process for the preparation of 3,4-dihydroxy-5-nitrobenzaldehyde, a key intermediate used in the synthesis of entacapone by demethylation of 5-nitrovanillin in absence of a base.
The present invention relates to substituted imidazo[4,5-c]quinoline derivatives, the compounds of formula (I), wherein R1 R2, R3, R4, R5, R6 and R7 are as defined in the specification, processes for their preparation, pharmaceutical compositions comprising compounds of formula (I), and their use in the treatment of...
The present invention provides an improved process for preparation of the L-threo—(2S,3R)—3-
'
(3.4-dihydroxyphenyl)serine (I), which is known as Droxidopa; comprising (a) reaction of the
aldehyde compound (III) (as described herein)with Metal complex (II) (as described herein),
and (b) hydrolysis of the compoun...
This invention relates to purified compound of formula (1). The invention includes all isomeric forms and all tautomeric forms of the compound of formula (1) and pharmaceutically acceptable salts thereof. The present invention further relates to processes for the production of the compound of formula (1) by fermenta...
The present invention relates to a biodegradable inhalable microparticle formulation comprising a compound of formula I obtained by fermentation of a microorganism of the Streptomyces species ( PM 0626271 /MTCC5447) as described in PCT application publication WO201 1027290 and a biodegradable lipid for drug delivery...
The present invention relates to an improved process for the preparation of 2-[2-(4-dibenzo [b,f] [l,4]thiazepin-ll-yl-l-piperazinyl)ethoxy]-ethanol (referred to as the compound-1), generically known as quetiapine. The process of the present invention further involves an improved process for the preparation of queti...
The present invention relates to an improved process for producing dibenzyl{3-[2(R)-[(lR)-l-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)morphoIin-4-yl]-5-oxo-4,5-dihydro-[l,2,4]-triazol-l-yl]phosphonic acid (the compound of formula I) in a solid form, comprising dissolving the compound of formula I ...
The invention relates to a method for the treatment of tuberculosis comprising administering to a subject in need thereof a therapeutically effective amount of the compound of Formula 1 (as provided in the description) or a stereoisomer a tautomer pharmaceutically acceptable salts thereof or derivatives thereof such...
The present invention provides an improved process for obtaining alpha (a)-form crystals of Mirabegron (I); comprising crystallizing solid compound (I) (as described herein) from water. The present invention provides an improved process for obtaining alpha (a)-form crystals of Mirabegron (I); comprising the steps of...
The present invention relates to a pharmaceutical combination comprising paclitaxel or its pharmaceutically acceptable salt; and at least one cyclin dependent kinase (CDK) inhibitor represented by a compound of formula I (as described herein) or a pharmaceutically acceptable salt thereof for use in the treatment of ...
The present invention provides an improved process for the preparation of 3-(4-chlorophenyl)-3-
cyanopropanoic acid (compound (A)) and further its transformation to Baclofen (I). The process
comprises reaction of compound (II) with Glyoxylic acid to obtain 3-(4-chlorophenyl)-3-
cyanoacrylic acid (HI); followed by...
The present invention relates to a green process for the preparation of 2,3-dihydro-5,6-dimethoxy-2-[[l-(phenylmethyl)-4-piperidinyl]methyl]-IH-inden-l-one hydrochloride (donepezil hydrochloride) of formula I comprising benzylation of compound of formula II with benzyl halide in the presence of an aqueous medium to ...
The present invention relates to an improved process for the preparation of Losartan (l-[l-[[2"-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2-butyl-4-chloro-lH-imidazoI-5-yl]methanol) represented by the compound of formula I; comprising reacting 4"-(2-Butyl-4-chloro-5-hydroxymethyl-1 H-imidazol-1 -yl)-1,1"-biphenyl-2-ca...
The present invention relates to a compound of formula (I) or a tautomer stereoisomer geometrical isomer prodrug carboxylic acid isostere solvate polymorph N oxide S oxide or pharmaceutically acceptable salt thereof which are GPR120 agonists. The present invention also relates to a pharmaceutical composition of a co...
The present invention relates to substituted imidazo[4 5 c]quinoline derivatives of formula (I) wherein R R and R are as defined in the specification processes for their preparation pharmaceutical compositions comprising compounds of the present invention and their use in the treatment of diseases or disorders media...
The present invention relates to an herbal composition comprising a therapeutically effective amount of the extract of a plant belonging to Calophyllum species as an active ingredient and optionally a pharmaceutically acceptable carrier. The present invention also relates to herbal composition comprising extract obt...
The present invention provides a substrate for a microfluidic device comprising a polymeric base plate at least one sensor formed over the polymeric base plate for detecting at least one target analyte from a sample the sensor comprising at least one reference electrode and at least one working electrode wherein a p...
The present invention provides an improved process for the prep^atipn_of Jstprotected
((3S54R)-4-(4-fluorophenyl)piperidin-3-yl)methanol (compound (A)) and further its transformation to Paroxetine and its pharmaceutically acceptable salts. The process comprises reaction of compound (II) with amido-malo...
The present invention relates to a stable, non-aqueous and ready-to-use injectable composition of a peptide drug or a pharmaceutically acceptable salt or a co-crystal thereof; and processes for its preparation. It is not required to reconstitute the injectable composition of the peptide drug with water prior to admi...
The present invention relates to a stable, non-aqueous and ready-to-use injectable composition of a pharmaceutically active agent a pharmaceutically active agent or a pharmaceutically acceptable salt or a co-crystal thereof. The present invention also relates to a process for the preparation of the stable, non-aqueo...
The present invention relates to a stable and ready-to-use injectable composition of a protein drug or a pharmaceutically acceptable salt or a co-crystal thereof; and processes for its preparation. It is not required to reconstitute the injectable composition of the protein drug with water prior to administration, t...
The present invention relates to a non-aqueous, stable and ready-to-use injectable composition of bivalirudin or pharmaceutically acceptable salt(s) or co-crystals thereof; and processes for its preparation. It is not required to reconstitute the injectable composition of bivalirudin with water prior to administrati...
The present invention relates to an industrially feasible and economically viable process for preparation of linagliptin of formula I in significantly high yield and purity.
Formula I
The present invention relates to an industrially feasible and economically viable process for preparation of tetrabenazine of formula I in significantly high yield and purity.
Formula I
The present invention relates to a herbal composition comprising a therapeutically effective amount of an extract of the plant as an active ingredient and optionally a pharmaceutically acceptable carrier. The invention also relates to a process for the preparation of the extract. The invention also relates to a meth...
The present invention relates to an improved process for producing the racemic 3-(carbamoylmethyl)-5-methylhexanoic acid (compound of formula I) from the (S)-isomer of the compound of formula I comprising heating the (S)-isomer of the compound of formula I with a metal salt as a catalyst in an organic solvent at a t...
This invention relates to an isolated compound of Formula (1) or derivatives or pharmaceutically acceptable salts thereof. The invention also includes all isomeric and tautomeric forms of the compound of Formula (1) or the derivatives thereof. The present invention further relates to processes for the production of ...
The present invention relates to an improved process for the preparation of the compound (R)-3-((3,5-dichloro-4’-(4-(trifluoromethyl)piperidine-1-carbonyl)-[1,1’-biphenyl]-4-yl)methyl)-1-(4-hydroxypiperidin-1-yl)pyrrolidin-2-onem (compound of formula (I)), which is an inhibitor of 11ß-hydroxysteroid dehydrogenase ty...
The present invention relates to a composition comprising extract of the plant . The invention also relates to a process for the preparation of the composition and to the composition for the use in the treatment of viral infections particularly caused by herpes simplex viruses (HSV). The invention further relates to...
The present invention relates to a novel process for the preparation of an intermediate of fosaprepitant dimeglumine. The present invention particularly relates to a process for the preparation of fosaprepitant dibenzyl ester, an intermediate of fosaprepitant dimeglumine, which is simple, easy to handle on commercia...
The present invention relates to a process for the preparation of the compounds of formula (I) which are morpholino sulphonyl indole derivatives. The compounds of formula (I) are capable of inhibiting modulating or regulating Insulin Like Growth Factor I Receptors or Insulin Receptors. The present invention also rel...
The present invention relates to a novel process for the preparation of intermediate of fosaprepitant dimeglumine. The present invention particularly relates to a process for the preparation of fosaprepitant dibenzyl ester, an intermediate of fosaprepitant dimeglumine, which is simple, easy to handle on commercial s...
The present invention relates to a crystalline form of a pharmaceutically acceptable salt of a morpholino sulphonyl indole derivative that is capable of inhibiting modulating and/or regulating Insulin Like Growth Factor I Receptor and Insulin Receptor. The present invention also relates to a process for the preparat...
The present invention provides an improved process for preparation of organic compounds represented by Formula-Z; wherein effectively minimising the formation of dehalogenated by-products is achieved. In the process, the reduction is carried out using suitable reducing agent; more preferably Lithium Aluminium Hydrid...
The present invention provides compounds represented by general formula (I): wherein, R1; R2, R3, L and T are as defined in the specification, in all their stereoisomeric and tautomeric forms and mixtures thereof in all ratios, and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, and pr...
A system for detecting an adulterant in a sample of milk. One or more drops of milk are added to a first location of a system and the presence or absence of the adulterant is detected in a second location of the system using a material treated with a detection reagent.
The present invention discloses fused triterpene compounds represented by the compounds of Formula I (as described herein) processes for their preparation pharmaceutical compositions comprising the said compounds their use as retinoid related orphan receptors gamma (ROR?) modulators and/or interleukin 17 (IL 17) inh...
The present invention relates to an improved process for the preparation of [3-
{[(2R,35)-2-[(lR)-l-[3,5-bis(trifluoromethyl)phenyI] ethoxy]-3-(4-
fluorophenyl)morpholin-4-yl]methyl}-5-oxo- 2H-l,2,4-triazol-l-yl]phosphonic acid (Fosaprepitant or the compound of formula I) or its pharmaceutically acceptable salt, h...
Fused pyrimidines of formula (I):
wherein
A represents a thiophene or furan ring;
n is 1 or 2;
R1 is a group of formula:
wherein m is 0 or 1;
R30 is H or C1-C6 alkyl;
R4 and R5 form, together with the N atom to which they are attached, a 5- or 6-membered saturated N-containing heterocyclic group which include...
Fused pyrimidines of formula (I):
wherein
A represents a thiophene or furan ring;
n is 1 or 2;
Rl is a group of formula:
wherein m is 0 or 1;
R30 is H or C1-C6 alkyl;
R4 and R5 form, together with the N atom to which they are attached, a 5- or 6-membered saturated N-containing heterocyclic group which incl...
A control system for remotely controlling the operation of a water distribution system is disclosed. The control system comprises of a communication interface to enable communication between the control system and the water distribution system such that communication includes receiving from the water distribution sy...
A water distribution system configured forcontrol by a remote control system is disclosed comprising of a water filtration unit for filtering water and a water storage unit for storing the filtered water and including a water dispenser.A control unit is provided that is configured to control the operation of the wat...
The present invention relates to an improved process for the preparation of 2-butyl-3-[[2"-(2H-tetrazol5yl[1,1"-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one, the compound of formula I (Irbesartan) comprising reacting 4"-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1 -en-3-yl)methyl]-[l, 1 "-Biphenyl]-2-carboni...
The present invention relates to an improved process for the preparation of (2S,3aS,7aS)-l-[(2S)-2-[[(lS)-l-(ethoxycarbonyl)butyl]amino]-l-oxopropyI]octahydro-lH-indole-2-carboxylic acid benzyl ester( the compound of formula II) comprising reacting (2S,3aS,7aS)-octahydro-IH-indole-2-carboxylic acid phenylmethyl este...
The present invention relates to a process for the preparation of 5-(3,4-dimethoxyphenylethyl) methyl-amino-2-(3,4-dimethoxyphenyi)-2-isopropyl valeronitrile, which is known as Verapamil. The present invention also relates to a process for improving the purity of verapamil and therefore of its hydrochloride represen...
The present invention relates to phenyl alkanoic acid derivatives (the compounds of Formula (I)); and their isotopic forms stereoisomeric and tautomeric forms and mixtures thereof in all ratios or pharmaceutically acceptable salts pharmaceutically acceptable solvates prodrugs polymorphs N oxides S oxides or carboxyl...
The present invention relates to the pyrrolidine substituted with flavone derivatives represented by the compounds of Formula (I) (as described herein) or pharmaceutically acceptable salts solvates stereoisomers or diastereoisomers thereof or pharmaceutical compositions containing the compounds of Formula (I) for us...
The present invention relates to substituted phenyl alkanoic acid compounds designated as the compound of Formula (I) (as described herein) or a tautomer a stereoisomer a geometrical isomer a pharmaceutically acceptable salt a pharmaceutically acceptable solvate a prodrug a polymorph an N oxide a S oxide or a carbox...
ABSTRACT
ORAL PHARMACEUTICAL COMPOSITION OF LURASIDONE AND PREPARATION THEREOF
The present invention relates to an oral pharmaceutical composition, particularly a tablet, comprising an active ingredient lurasidone or its pharmaceutically acceptable salt(s) or solvate(s) thereof and one or more pharmaceutical e...
ABSTRACT
The present invention provides an improved process for preparation of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine; commonly known as vortioxetine (referred to as the compound (I)) and pharmaceutically acceptable salts thereof; wherein the process comprises reaction of 2-((2,4-dimethylphenyl)thi...
The present invention provides an improved process for preparation of (8R,9S,10R,13S,14S,17R)-10,13-dimethyl-1,3",4",8,9,10,11,12,13,14,15,16-dodecahydro-5"H-spiro[cyclopenta[a]phenanthrene-17,2"-furan]-3,5"(2H)-dione; commonly known as Canrenone (referred to as the compound (A)), pharmaceutically acceptable salts t...
ABSTRACT
AN IMPROVED PROCESS FOR THE PREPARATION
OF DROXIDOPA AND ITS INTERMEDIATE
The present invention provides an improved process for preparation of the L-threo-(2S,3R)-3-(3,4-dihydroxyphenyl)serine (I) or a salt thereof, which is known as Droxidopa; comprising (a) recovery of the by-product compound (...
The present invention relates to compound of Formula (I) containing carbon carbon linker a stereoisomer a tautomer a pharmaceutically acceptable salt a pharmaceutically acceptable solvate a prodrug a polymorph N oxide S oxide or a carboxylic acid isostere thereof; processes for their preparation; pharmaceutical comp...
The present invention provides a process for the preparation of cinacalcet (the compound of formula I) or its pharmaceutically acceptable salts involving reaction of the compound of formula II with the compound of formula III using sulphuric acid to yield imine (the compound of formula IV) and followed by reduction ...
The present invention relates to heterocyclic compounds of Formula (1) in all their stereoisomeric and tautomeric forms; and their pharmaceutically acceptable salts solvates polymorphs prodrugs carboxylic acid isosteres and N oxides. The invention also relates to processes for the manufacture of the heterocyclic com...
The present invention relates to a process for the preparation of [(2R, 4S)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl 4-methyl benzene sulphonate, referred to as 'Cis-Tosylate'. The present invention also relates to a process for preparing a substantially pure cis-tosylate having purity...
The present invention relates to a standardised extract of Momordica Charantia containing one or more nitrogen containing heterocyclic compounds as the bioactive markers and a process for the preparation thereof. The present invention also relates to a composition comprising the standardised extract of Momordica Cha...
The present invention relates to a compound of formula I or an isotopic form stereoisomer a tautomer a pharmaceutically acceptable salt a solvate a polymorph a prodrug N oxide or S oxide thereof; and processes for their preparation. The invention further relates to pharmaceutical compositions containing the compound...
ABSTRACT
The present invention relates to an improved process for the preparation of 1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethan-1-amine (A). , which is useful as a key intermediate for the synthesis of Apremilast (N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-...
ABSTRACT
The present invention relates to an industrially feasible and economically viable process for preparation of SGLT2 inhibitors of formula X in significantly high yield and purity.
Formula X
To
The Controller of Patents
The Patent Office
At Mumbai
ABSTRACT
The present invention relates to an industrially feasible and economically viable process for preparation of Canagliflozin of formula I in significantly high yield and purity.
Formula I
To
The Controller of Patents
The Patent Office
At Mumbai
ABSTRACT
The present invention provides an improved process for preparation of pure N-(2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide (1) (commonly known as Apremilast); wherein the content of des-acetyl apremilast (1a) is less than 1% w/w and having total amount of ge...
ABSTRACT
AN IMPROVED ASYMMETRIC SYNTHESIS OF alpha-(DIARYLMETHYL) ALKYL AMINES
The present invention relates to an improved asymmetric synthesis of alpha-(diarylmethyl) alkyl amines (hereafter referred to as the compound (1)) or its pharmaceutically acceptable salt and derivatives. The process comprises an ...
ABSTRACT
AN IMPROVED ASYMMETRIC SYNTHESIS OF alpha-BRANCHED CHIRAL AMINES
The present invention relates to an improved asymmetric synthesis of alpha-branched amines (hereafter referred to as the compound (1)) and relative chiral amines (1”) or its pharmaceutically acceptable salt and derivatives. The process ...
ABSTRACT
SOLID STATE FORMS OF REGADENOSON
The present invention relates to a N-Methyl-2-pyrrolidone (NMP) solvate and stable Form C of Regadenoson and preparation thereof.
To,
The Controller of Patents
The Patent Office
At Mumbai
ABSTRACT
The present invention relates to an industrially feasible and economically viable process for preparation of Bexagliflozin of formula V in significantly high yield and purity.
Formula V
ABSTRACT
AN IMPROVED LED BASED PHOTOCHEMICAL REACTOR
The present invention provides an improved photochemical rector assembly device, particularly a light emitting diode (LED) based small photochemical reactor and methods for performing the photochemical transformations using the instantly presented device. ...
ABSTRACT
AN IMPROVED PROCESS FOR DIASTEREOSELECTIVE SYNTHESIS OF VICINAL DIAMINES
The present invention relates to an improved process for diastereoselective synthesis of vicinal diamines (1). The process involves highly regio- and diastereoselective addition of 2-azaallyl anions (4) to N-tert-butanesulfin...
MONITORING QUALITY OF PHARMACEUTICAL MANUFACTURING SITES
The present invention relates to a level meter measuring the quality health of a pharmaceutical manufacturing site and which predicts 24/7 audit readiness for quality outcomes, wherein outcome is interpreted using tangible data; referred to as a Quality Hea...
ELECTROCHEMICAL ORGANIC REACTION SETUP AND METHODS
ABSTRACT
The present invention provides to a simple and efficient electrochemical organic reaction setup, particularly to carry out electrolysis reactions in chemistry laboratory and methods for performing the same with good yield and less impurity formation u...
ABSTRACT
AN IMPROVED ASYMMETRIC SYNTHESIS OF AZASPIRO COMPOUNDS
The present invention relates to an improved asymmetric synthesis of azaspiro or di-azaspiro compound (hereafter referred to as the compound 5, (5A) or (5N)) or their pharmaceutically acceptable salts and derivatives; through the formation of int...
ABSTRACT
AN IMPROVED PROCESS FOR THE PREPARATION
OF ELIGLUSTAT AND ITS INTERMEDIATE
The present invention relates to an improved process for the preparation of N-((1R,2R)-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)octanamide (A), which is known as ELIGLUSTAT and its ph...
The present invention provides an improved process for the preparation of pure 4-(3,5-bis(2-hydroxyphenyl)-lH-l,2,4-triazol-l-yl)benzoic acid (I) commonly known as Deferasirox or its salt containing hydrazine impurity less than about 0.75 ppm; comprising treating the crude deferasirox with oxone.
In addition, the p...
Registered Trademarks
[Class : 25] Clothing; Footwear And Headwear For Human Beings; Baby Pants; Baby Tops; Baby Bodysuits; Baby Bottoms; Baby Clothes; Baby Bibs; Baby Shoes; Baby Boots; Baby Sandals; Knitted Baby Shoes; Booties; Infant Wear; Infant’s Clothing; Infant’s Footwear; Socks For Infants And Toddlers; Children’s Wear; Children’s Clothing; Children’s Footwear; Children’s Headwear.
[Class : 5] Pharmaceuticals, Medical And Veterinary Preparations; Dietetic Food And Substances Adapted For Medical Or Veterinary Use, Food For Babies; Dietary Supplements For Human Beings And Animals; Dietary Supplements Intended To Supplement A Normal Diet Or To Have Health Benefits; Meal Replacements And Dietetic Food And Beverages Adapted For Medical Or Veterinary Use; Di...
[Class : 3] Bleaching Preparations And Other
Substances For Laundry Use; Cleaning
Polishing; Scouring And Abrasive
Preparations; Soaps; Perfumery. Essential
Oils. Cosmetics. Hair Lotion. Hair Care
Preparations. Skin Care Preparations. Non Medicated
Toilet Preparations Containing
Calamine For The Skin. Dentifrices
View +106 more Brands for Piramal Enterprises Limited.
Charges
15 September 2019
Catalyst Trusteeship Limited
1,600 Crore
20 August 2019
Idbi Trusteeship Services Limited
300 Crore
11 July 2019
Catalyst Trusteeship Limited
1,500 Crore
23 January 2019
Idbi Trusteeship Services Limited
500 Crore
27 December 2018
Catalyst Trusteeship Limited
600 Crore
21 December 2018
Idbi Trusteeship Services Limited
500 Crore
07 December 2018
Idbi Trusteeship Services Limited
1,020 Crore
08 December 2017
Idbi Trusteeship Services Limited
2,000 Crore
28 August 2017
Hdfc Bank Limited
275 Crore
20 July 2017
Idbi Trusteeship Services Limited
500 Crore
15 November 2016
Idbi Trusteeship Services Limited
2,500 Crore
28 July 2016
Idbi Trusteeship Services Limited
200 Crore
23 May 2016
Idbi Trusteeship Services Limited
1,000 Crore
20 January 1998
Allahabad Bank
500 Crore
06 June 1997
Dresdner Bank Ag
65 Lak
15 November 1991
Unit Trust Of India
3 Crore
07 December 1982
Canara Bank
20 Lak
21 November 2018
Catalyst Trusteeship Limited
1,000 Crore
17 January 2017
Idbi Trusteeship Services Limited
150 Crore
04 March 2016
Idbi Trusteeship Services Limited
500 Crore
08 August 2016
Idbi Trusteeship Services Limited
250 Crore
10 June 2016
Idbi Trusteeship Services Limited
300 Crore
30 March 2013
Idbi Trusteeship Services Limited
350 Crore
25 February 2015
The Hongkong And Shanghai Banking Corporation Limited
100 Crore
30 September 2015
Idbi Trusteeship Services Limited
500 Crore
30 March 2016
Idbi Trusteeship Services Limited
350 Crore
22 April 2016
Idbi Trusteeship Services Limited
250 Crore
24 February 2009
Idbi Trusteeship Services Limited
150 Crore
27 April 1998
Ing Bank N.a
1 Crore
23 July 2002
Bank Of America
125 Crore
13 March 2002
Icici Bank Ltd.
6 Crore
18 September 2012
Standard Chartered Bank
3,575 Crore
25 March 2009
Allahabad Bank
60 Crore
23 October 2009
3i Infotech Trusteeship Services Limited
3 Crore
24 February 2009
Idbi Trusteeship Services Limited
200 Crore
31 May 2004
Bnp Paribas Singapore
45 Crore
31 May 2004
Citi Bank N. A.
22 Crore
31 May 2004
Citc Bank
2 Crore
28 March 2003
Il & Fs Trust Company Ltd.
0
04 September 2003
Cooperatieve Centrale Raiffeisen Boerneleenbank B.a
47 Crore
04 September 2003
Cooperatieve Centrale Raiffeisen Boerenleenbank B.a
47 Crore
27 April 2002
Hdfc Bank Ltd.
35 Crore
25 January 1988
Industrial Finance Corpo. Of India
1 Crore
20 July 1987
Industrial Finance Corpo. Of India
36 Lak
03 December 1990
Industrial Finance Corpo. Of India
20 Lak
11 February 1987
Industrial Finance Corpo. Of India
36 Lak
09 March 1990
Industrial Development Bank Of India
2 Crore
15 June 1990
Industrial Development Bank Of India
88 Lak
17 January 1991
The Industrial Credit & Investment Corp. Of India Ltd.
1 Crore
29 April 1995
Bank Of Baroda
5 Crore
25 September 1990
Bank Of Baroda
4 Crore
13 November 1992
Bank Of Baroda
75 Lak
28 September 1990
Bank Of Baroda
4 Crore
20 June 1994
Bank Of Baroda
1 Crore
04 April 1986
Bank Of Baroda
70 Lak
13 November 1992
Bank Of Baroda
75 Lak
13 October 1989
Allahabad Bank
6 Crore
22 February 1993
Allahabad Bank
13 Crore
31 March 1994
Allahabad Bank
24 Crore
18 October 1989
Allahabad Bank
6 Crore
09 January 1996
The Honkong & Shanghai Banking Corpo. Ltd.
3 Crore
15 February 1990
Oriental Bank Of Commerce
1 Crore
15 February 1990
Oriental Bank Of Commerce
1 Crore
07 October 1966
Standard Charterd
6 Lak
24 December 1985
Standard Chartered Bank
1 Crore
15 February 1993
Icici Ltd.
9 Crore
15 February 1993
The Indu. Credit & Inve. Corpo. Of India Ltd.
9 Crore
05 June 1998
Icici Ltd.
65 Crore
31 March 2001
Icici Bank Ltd.
200 Crore
29 June 1998
Icici Ltd.
25 Crore
17 April 1998
Ing Bank N.v
1 Crore
11 February 1997
Industrial Credit & Inve. Corop. Of India Ltd.
25 Crore
13 January 1997
The Industrial Credit & Investment Corporation Of India Ltd.
18 Crore
13 January 1997
The Indu. Credit & Inve. Corpo. Of India Ltd.
18 Crore
25 January 1988
The Indus. Credit & Inve. Corpo. Of India
1 Crore
29 July 1991
The Industrial Credit & Inve. Corpo. Of India Ltd.
1 Crore
20 December 1991
The Industrial Credit & Inve. Corp. Of India Ltd.
8 Crore
10 July 1997
Stangara Charterad Bank
25 Crore
26 October 2023
Others
0
27 October 2023
Idbi Trusteeship Services Limited
0
27 September 2023
Idbi Trusteeship Services Limited
0
14 August 2023
Idbi Trusteeship Services Limited
0
31 July 2023
Idbi Trusteeship Services Limited
0
04 November 2022
Others
0
28 June 2023
Idbi Trusteeship Services Limited
0
30 June 2023
Idbi Trusteeship Services Limited
0
Not available
Idbi Trusteeship Services Limited
0
02 January 2023
Others
0
30 January 2023
Others
0
12 September 2022
Idbi Trusteeship Services Limited
0
30 March 2023
Idbi Trusteeship Services Limited
0
31 March 2023
Idbi Trusteeship Services Limited
0
28 March 2023
Others
0
22 November 2022
Idbi Trusteeship Services Limited
0
23 June 2020
Others
0
04 July 2020
Others
0
20 July 2017
Idbi Trusteeship Services Limited
0
31 March 2022
The Hongkong And Shanghai Banking Corporation Limited
0
18 August 2020
Idbi Trusteeship Services Limited
0
20 January 2021
Idbi Trusteeship Services Limited
0
29 September 2021
Idbi Trusteeship Services Limited
0
04 January 2021
Idbi Trusteeship Services Limited
0
02 December 2021
Idbi Trusteeship Services Limited
0
26 October 2021
Idbi Trusteeship Services Limited
0
12 December 2020
Others
0
22 June 2021
Idbi Trusteeship Services Limited
0
04 March 2016
Idbi Trusteeship Services Limited
0
18 October 1989
Allahabad Bank
0
15 November 1991
Unit Trust Of India
0
01 September 2020
Idbi Trusteeship Services Limited
0
06 July 2020
Others
0
20 March 2020
Others
0
11 February 2020
Idbi Trusteeship Services Limited
0
31 January 2020
Others
0
28 January 2020
Standard Chartered Bank
0
28 January 2020
Idbi Trusteeship Services Limited
0
28 December 2019
Others
0
28 December 2019
Others
0
29 November 2019
Others
0
25 November 2019
Others
0
20 August 2019
Idbi Trusteeship Services Limited
0
15 September 2019
Others
0
23 January 2019
Idbi Trusteeship Services Limited
0
20 January 1998
Others
0
21 December 2018
Idbi Trusteeship Services Limited
0
07 December 2018
Idbi Trusteeship Services Limited
0
21 November 2018
Others
0
21 November 2018
Others
0
28 September 2018
Others
0
08 December 2017
Idbi Trusteeship Services Limited
0
17 January 2017
Idbi Trusteeship Services Limited
0
15 November 2016
Idbi Trusteeship Services Limited
0
28 July 2016
Idbi Trusteeship Services Limited
0
22 April 2016
Idbi Trusteeship Services Limited
0
30 March 2016
Idbi Trusteeship Services Limited
0
27 December 2018
Others
0
28 August 2017
Hdfc Bank Limited
0
24 February 2009
Idbi Trusteeship Services Limited
0
24 February 2009
Idbi Trusteeship Services Limited
0
23 October 2009
3i Infotech Trusteeship Services Limited
0
30 September 2015
Idbi Trusteeship Services Limited
0
31 May 2004
Bnp Paribas Singapore
0
24 December 1985
Standard Chartered Bank
0
04 April 1986
Bank Of Baroda
0
11 February 1987
Industrial Finance Corpo. Of India
0
20 July 1987
Industrial Finance Corpo. Of India
0
15 February 1990
Oriental Bank Of Commerce
0
03 December 1990
Industrial Finance Corpo. Of India
0
17 January 1991
The Industrial Credit & Investment Corp. Of India Ltd.
0
29 July 1991
The Industrial Credit & Inve. Corpo. Of India Ltd.
0
15 February 1993
The Indu. Credit & Inve. Corpo. Of India Ltd.
0
13 November 1992
Bank Of Baroda
0
22 February 1993
Allahabad Bank
0
31 March 1994
Allahabad Bank
0
11 February 1997
Industrial Credit & Inve. Corop. Of India Ltd.
0
06 June 1997
Dresdner Bank Ag
0
10 July 1997
Stangara Charterad Bank
0
17 April 1998
Ing Bank N.v
0
04 September 2003
Cooperatieve Centrale Raiffeisen Boerneleenbank B.a
0
07 December 1982
Canara Bank
0
13 March 2002
Icici Bank Ltd.
0
13 January 1997
The Industrial Credit & Investment Corporation Of India Ltd.
0
20 December 1991
The Industrial Credit & Inve. Corp. Of India Ltd.
0
13 January 1997
The Indu. Credit & Inve. Corpo. Of India Ltd.
0
05 June 1998
Icici Ltd.
0
04 September 2003
Cooperatieve Centrale Raiffeisen Boerenleenbank B.a
0
23 May 2016
Idbi Trusteeship Services Limited
0
23 July 2002
Bank Of America
0
08 August 2016
Idbi Trusteeship Services Limited
0
11 July 2019
Others
0
25 March 2009
Allahabad Bank
0
18 September 2012
Standard Chartered Bank
0
30 March 2013
Idbi Trusteeship Services Limited
0
25 February 2015
The Hongkong And Shanghai Banking Corporation Limited
0
25 September 1990
Bank Of Baroda
0
07 October 1966
Standard Charterd
0
25 January 1988
The Indus. Credit & Inve. Corpo. Of India
0
25 January 1988
Industrial Finance Corpo. Of India
0
13 October 1989
Allahabad Bank
0
09 March 1990
Industrial Development Bank Of India
0
15 June 1990
Industrial Development Bank Of India
0
28 September 1990
Bank Of Baroda
0
13 November 1992
Bank Of Baroda
0
20 June 1994
Bank Of Baroda
0
29 April 1995
Bank Of Baroda
0
27 April 1998
Ing Bank N.a
0
29 June 1998
Icici Ltd.
0
31 March 2001
Icici Bank Ltd.
0
09 January 1996
The Honkong & Shanghai Banking Corpo. Ltd.
0
15 February 1990
Oriental Bank Of Commerce
0
15 February 1993
Icici Ltd.
0
27 April 2002
Hdfc Bank Ltd.
0
28 March 2003
Il & Fs Trust Company Ltd.
0
31 May 2004
Citi Bank N. A.
0
31 May 2004
Citc Bank
0
10 June 2016
Idbi Trusteeship Services Limited
0
26 October 2023
Others
0
27 October 2023
Idbi Trusteeship Services Limited
0
27 September 2023
Idbi Trusteeship Services Limited
0
14 August 2023
Idbi Trusteeship Services Limited
0
31 July 2023
Idbi Trusteeship Services Limited
0
04 November 2022
Others
0
28 June 2023
Idbi Trusteeship Services Limited
0
30 June 2023
Idbi Trusteeship Services Limited
0
Not available
Idbi Trusteeship Services Limited
0
02 January 2023
Others
0
30 January 2023
Others
0
12 September 2022
Idbi Trusteeship Services Limited
0
30 March 2023
Idbi Trusteeship Services Limited
0
31 March 2023
Idbi Trusteeship Services Limited
0
28 March 2023
Others
0
22 November 2022
Idbi Trusteeship Services Limited
0
23 June 2020
Others
0
04 July 2020
Others
0
20 July 2017
Idbi Trusteeship Services Limited
0
31 March 2022
The Hongkong And Shanghai Banking Corporation Limited
0
18 August 2020
Idbi Trusteeship Services Limited
0
20 January 2021
Idbi Trusteeship Services Limited
0
29 September 2021
Idbi Trusteeship Services Limited
0
04 January 2021
Idbi Trusteeship Services Limited
0
02 December 2021
Idbi Trusteeship Services Limited
0
26 October 2021
Idbi Trusteeship Services Limited
0
12 December 2020
Others
0
22 June 2021
Idbi Trusteeship Services Limited
0
04 March 2016
Idbi Trusteeship Services Limited
0
18 October 1989
Allahabad Bank
0
15 November 1991
Unit Trust Of India
0
01 September 2020
Idbi Trusteeship Services Limited
0
06 July 2020
Others
0
20 March 2020
Others
0
11 February 2020
Idbi Trusteeship Services Limited
0
31 January 2020
Others
0
28 January 2020
Standard Chartered Bank
0
28 January 2020
Idbi Trusteeship Services Limited
0
28 December 2019
Others
0
28 December 2019
Others
0
29 November 2019
Others
0
25 November 2019
Others
0
20 August 2019
Idbi Trusteeship Services Limited
0
15 September 2019
Others
0
23 January 2019
Idbi Trusteeship Services Limited
0
20 January 1998
Others
0
21 December 2018
Idbi Trusteeship Services Limited
0
07 December 2018
Idbi Trusteeship Services Limited
0
21 November 2018
Others
0
21 November 2018
Others
0
28 September 2018
Others
0
08 December 2017
Idbi Trusteeship Services Limited
0
17 January 2017
Idbi Trusteeship Services Limited
0
15 November 2016
Idbi Trusteeship Services Limited
0
28 July 2016
Idbi Trusteeship Services Limited
0
22 April 2016
Idbi Trusteeship Services Limited
0
30 March 2016
Idbi Trusteeship Services Limited
0
27 December 2018
Others
0
28 August 2017
Hdfc Bank Limited
0
24 February 2009
Idbi Trusteeship Services Limited
0
24 February 2009
Idbi Trusteeship Services Limited
0
23 October 2009
3i Infotech Trusteeship Services Limited
0
30 September 2015
Idbi Trusteeship Services Limited
0
31 May 2004
Bnp Paribas Singapore
0
24 December 1985
Standard Chartered Bank
0
04 April 1986
Bank Of Baroda
0
11 February 1987
Industrial Finance Corpo. Of India
0
20 July 1987
Industrial Finance Corpo. Of India
0
15 February 1990
Oriental Bank Of Commerce
0
03 December 1990
Industrial Finance Corpo. Of India
0
17 January 1991
The Industrial Credit & Investment Corp. Of India Ltd.
0
29 July 1991
The Industrial Credit & Inve. Corpo. Of India Ltd.
0
15 February 1993
The Indu. Credit & Inve. Corpo. Of India Ltd.
0
13 November 1992
Bank Of Baroda
0
22 February 1993
Allahabad Bank
0
31 March 1994
Allahabad Bank
0
11 February 1997
Industrial Credit & Inve. Corop. Of India Ltd.
0
06 June 1997
Dresdner Bank Ag
0
10 July 1997
Stangara Charterad Bank
0
17 April 1998
Ing Bank N.v
0
04 September 2003
Cooperatieve Centrale Raiffeisen Boerneleenbank B.a
0
07 December 1982
Canara Bank
0
13 March 2002
Icici Bank Ltd.
0
13 January 1997
The Industrial Credit & Investment Corporation Of India Ltd.
0
20 December 1991
The Industrial Credit & Inve. Corp. Of India Ltd.
0
13 January 1997
The Indu. Credit & Inve. Corpo. Of India Ltd.
0
05 June 1998
Icici Ltd.
0
04 September 2003
Cooperatieve Centrale Raiffeisen Boerenleenbank B.a
0
23 May 2016
Idbi Trusteeship Services Limited
0
23 July 2002
Bank Of America
0
08 August 2016
Idbi Trusteeship Services Limited
0
11 July 2019
Others
0
25 March 2009
Allahabad Bank
0
18 September 2012
Standard Chartered Bank
0
30 March 2013
Idbi Trusteeship Services Limited
0
25 February 2015
The Hongkong And Shanghai Banking Corporation Limited
0
25 September 1990
Bank Of Baroda
0
07 October 1966
Standard Charterd
0
25 January 1988
The Indus. Credit & Inve. Corpo. Of India
0
25 January 1988
Industrial Finance Corpo. Of India
0
13 October 1989
Allahabad Bank
0
09 March 1990
Industrial Development Bank Of India
0
15 June 1990
Industrial Development Bank Of India
0
28 September 1990
Bank Of Baroda
0
13 November 1992
Bank Of Baroda
0
20 June 1994
Bank Of Baroda
0
29 April 1995
Bank Of Baroda
0
27 April 1998
Ing Bank N.a
0
29 June 1998
Icici Ltd.
0
31 March 2001
Icici Bank Ltd.
0
09 January 1996
The Honkong & Shanghai Banking Corpo. Ltd.
0
15 February 1990
Oriental Bank Of Commerce
0
15 February 1993
Icici Ltd.
0
27 April 2002
Hdfc Bank Ltd.
0
28 March 2003
Il & Fs Trust Company Ltd.
0
31 May 2004
Citi Bank N. A.
0
31 May 2004
Citc Bank
0
10 June 2016
Idbi Trusteeship Services Limited
0
01 November 2023
Idbi Trusteeship Services Limited
0
29 December 2023
Idbi Trusteeship Services Limited
0
27 October 2023
Others
0
29 November 2023
Others
0
26 October 2023
Others
0
27 October 2023
Idbi Trusteeship Services Limited
0
27 September 2023
Idbi Trusteeship Services Limited
0
14 August 2023
Idbi Trusteeship Services Limited
0
31 July 2023
Idbi Trusteeship Services Limited
0
04 November 2022
Others
0
28 June 2023
Idbi Trusteeship Services Limited
0
30 June 2023
Idbi Trusteeship Services Limited
0
Not available
Idbi Trusteeship Services Limited
0
02 January 2023
Others
0
30 January 2023
Others
0
12 September 2022
Idbi Trusteeship Services Limited
0
30 March 2023
Idbi Trusteeship Services Limited
0
31 March 2023
Idbi Trusteeship Services Limited
0
28 March 2023
Others
0
22 November 2022
Idbi Trusteeship Services Limited
0
04 July 2020
Others
0
23 June 2020
Others
0
20 January 2021
Idbi Trusteeship Services Limited
0
29 September 2021
Idbi Trusteeship Services Limited
0
04 January 2021
Idbi Trusteeship Services Limited
0
31 March 2022
The Hongkong And Shanghai Banking Corporation Limited
0
20 July 2017
Idbi Trusteeship Services Limited
0
18 August 2020
Idbi Trusteeship Services Limited
0
26 October 2021
Idbi Trusteeship Services Limited
0
02 December 2021
Idbi Trusteeship Services Limited
0
20 January 1998
Others
0
15 November 1991
Unit Trust Of India
0
22 April 2016
Idbi Trusteeship Services Limited
0
28 July 2016
Idbi Trusteeship Services Limited
0
15 November 2016
Idbi Trusteeship Services Limited
0
17 January 2017
Idbi Trusteeship Services Limited
0
08 December 2017
Idbi Trusteeship Services Limited
0
28 September 2018
Others
0
21 November 2018
Others
0
21 November 2018
Others
0
07 December 2018
Idbi Trusteeship Services Limited
0
21 December 2018
Idbi Trusteeship Services Limited
0
27 December 2018
Others
0
23 January 2019
Idbi Trusteeship Services Limited
0
15 September 2019
Others
0
20 August 2019
Idbi Trusteeship Services Limited
0
25 November 2019
Others
0
29 November 2019
Others
0
28 December 2019
Others
0
28 December 2019
Others
0
28 January 2020
Idbi Trusteeship Services Limited
0
28 January 2020
Standard Chartered Bank
0
31 January 2020
Others
0
11 February 2020
Idbi Trusteeship Services Limited
0
20 March 2020
Others
0
06 July 2020
Others
0
01 September 2020
Idbi Trusteeship Services Limited
0
12 December 2020
Others
0
22 June 2021
Idbi Trusteeship Services Limited
0
04 March 2016
Idbi Trusteeship Services Limited
0
18 October 1989
Allahabad Bank
0
30 March 2016
Idbi Trusteeship Services Limited
0
31 March 1994
Allahabad Bank
0
11 February 1997
Industrial Credit & Inve. Corop. Of India Ltd.
0
06 June 1997
Dresdner Bank Ag
0
10 July 1997
Stangara Charterad Bank
0
17 April 1998
Ing Bank N.v
0
04 September 2003
Cooperatieve Centrale Raiffeisen Boerneleenbank B.a
0
07 December 1982
Canara Bank
0
13 March 2002
Icici Bank Ltd.
0
13 January 1997
The Industrial Credit & Investment Corporation Of India Ltd.
0
20 December 1991
The Industrial Credit & Inve. Corp. Of India Ltd.
0
13 January 1997
The Indu. Credit & Inve. Corpo. Of India Ltd.
0
05 June 1998
Icici Ltd.
0
04 September 2003
Cooperatieve Centrale Raiffeisen Boerenleenbank B.a
0
28 August 2017
Hdfc Bank Limited
0
24 February 2009
Idbi Trusteeship Services Limited
0
24 February 2009
Idbi Trusteeship Services Limited
0
23 October 2009
3i Infotech Trusteeship Services Limited
0
30 September 2015
Idbi Trusteeship Services Limited
0
31 May 2004
Bnp Paribas Singapore
0
24 December 1985
Standard Chartered Bank
0
04 April 1986
Bank Of Baroda
0
11 February 1987
Industrial Finance Corpo. Of India
0
20 July 1987
Industrial Finance Corpo. Of India
0
15 February 1990
Oriental Bank Of Commerce
0
03 December 1990
Industrial Finance Corpo. Of India
0
17 January 1991
The Industrial Credit & Investment Corp. Of India Ltd.
0
29 July 1991
The Industrial Credit & Inve. Corpo. Of India Ltd.
0
15 February 1993
The Indu. Credit & Inve. Corpo. Of India Ltd.
0
13 November 1992
Bank Of Baroda
0
22 February 1993
Allahabad Bank
0
13 November 1992
Bank Of Baroda
0
28 September 1990
Bank Of Baroda
0
29 April 1995
Bank Of Baroda
0
27 April 1998
Ing Bank N.a
0
29 June 1998
Icici Ltd.
0
31 March 2001
Icici Bank Ltd.
0
09 January 1996
The Honkong & Shanghai Banking Corpo. Ltd.
0
15 February 1990
Oriental Bank Of Commerce
0
15 February 1993
Icici Ltd.
0
27 April 2002
Hdfc Bank Ltd.
0
28 March 2003
Il & Fs Trust Company Ltd.
0
31 May 2004
Citi Bank N. A.
0
31 May 2004
Citc Bank
0
23 July 2002
Bank Of America
0
23 May 2016
Idbi Trusteeship Services Limited
0
10 June 2016
Idbi Trusteeship Services Limited
0
08 August 2016
Idbi Trusteeship Services Limited
0
11 July 2019
Others
0
25 March 2009
Allahabad Bank
0
18 September 2012
Standard Chartered Bank
0
30 March 2013
Idbi Trusteeship Services Limited
0
25 February 2015
The Hongkong And Shanghai Banking Corporation Limited
0
25 September 1990
Bank Of Baroda
0
07 October 1966
Standard Charterd
0
25 January 1988
The Indus. Credit & Inve. Corpo. Of India
0
25 January 1988
Industrial Finance Corpo. Of India
0
13 October 1989
Allahabad Bank
0
09 March 1990
Industrial Development Bank Of India
0
15 June 1990
Industrial Development Bank Of India
0
20 June 1994
Bank Of Baroda
0
Documents
Form MGT-15-30072024_signed
Form MSME FORM I-29042024_signed
Optional Attachment-(2)-22032024
Optional Attachment-(3)-22032024
Optional Attachment-(1)-22032024
Form Addendum to AOC-4 CSR-22032024
Form MGT-6-21022024_signed
Optional Attachment-(1)-21022024
-21022024
Form MGT-6-30012024_signed
-30012024
Form MGT-6-19012024_signed
Form MGT-6-17012024_signed
Form MGT-6-16012024_signed
Form MGT-6-03012024_signed
Form MGT-6-22122023_signed
-22122023
Form MGT-6-29112023_signed
-27112023
Form BEN - 2-18112023_signed
Form BEN - 2-17112023_signed
Form MGT-6-09112023
Optional Attachment-(1)-09112023
-09112023
Form MSME FORM I-28102023
Form MGT-6-02112023
Optional Attachment-(1)-02112023
-02112023
-01112023
Optional Attachment-(1)-01112023
